Niederburg, Germany

Gisela Bodenbach

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Ummendorf, DE (2004 - 2005)
  • Niederburg, DE (2008)

Company Filing History:


Years Active: 2004-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Gisela Bodenbach: Innovator in Pharmaceutical Processes

Introduction

Gisela Bodenbach is a notable inventor based in Niederburg, Germany. She has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. Her work primarily focuses on innovative processes that enhance the preparation and reworking of pharmaceutical compounds.

Latest Patents

One of her latest patents is titled "Process of reworking a crystalline form of a glycine transport inhibitor." This invention describes a method for reworking a crystallization product that involves drying and homogenization. The crystallization product is a complex compound known as [5-(methylsulfonyl)-2-{[(2R)-1,1,1-trifluoropropan-2-yl]oxy}phenyl]{(1R,5R)-1-[5-(trifluoromethyl)-1,2-oxazol-3-yl]-3-azabicyclo[3.1.0]hex-3-yl}methanone. The process includes drying the product in a tray dryer or pan dryer, followed by homogenization. Another significant patent is for an "Industrial process for preparing tropenol," which relates to a new industrially usable method for preparing tropenol, including its acid addition salts.

Career Highlights

Gisela has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim International GmbH. Her experience in these organizations has allowed her to develop and refine her innovative processes.

Collaborations

Throughout her career, Gisela has collaborated with esteemed colleagues such as Rolf Banholzer and Andreas Mathes. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Gisela Bodenbach is a pioneering inventor whose work in pharmaceutical processes has led to valuable innovations. Her contributions continue to impact the industry positively, showcasing her expertise and dedication to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…